MSRA rs4306591: What Your Genotype Means
The genetic variant rs4306591 is a common single nucleotide polymorphism located in an intronic non-coding region of the MSRA gene on chromosome 8. Population-level genome-wide association studies (GWAS) have linked this genomic locus to subtle statistical shifts in body mass index, waist circumference, and related metabolic traits. However, its overall effect size is very small and the current evidence for direct biological causation remains limited.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| AA | Homozygous for the A allele at rs4306591. In population-based GWAS research, this common baseline genotype has not been primarily highlighted for heightened statistical risk of obesity-related anthropometric measures, reflecting average baseline population tendencies. | Informational |
| AG | Heterozygous carrier possessing one A allele and one G allele at rs4306591. This genotype reflects one copy of the allele statistically correlated in large-scale cohort studies with modest shifts in anthropometric traits, although any individual phenotypic impact remains clinically minor. | Informational |
| GG | Homozygous for two copies of the G allele at rs4306591. In epidemiological and GWAS literature, carrying two copies of this allele is associated with a tiny statistical increment in obesity-related parameters, though it does not cause clinical weight gain on its own. | Higher attention |
Genomic Location and Variant Classification
The single nucleotide polymorphism rs4306591 represents a standard single base substitution (A/G) situated on human chromosome 8 within the methionine sulfoxide reductase A (MSRA) gene region. Categorized within genetic databases as a non-coding intronic variant, rs4306591 does not alter the amino acid sequence of the resulting protein. Instead, variants of this type are evaluated in modern genomics as potential regulatory markers that may subtly modulate transcriptional activity, alternative splicing, or serve as genetic proxies (tag SNPs) in linkage disequilibrium with neighboring functional variants. Because it resides in an intronic interval, having a specific allele does not break or disable the gene. Large-scale sequencing databases such as dbSNP, 1000 Genomes, and gnomAD record both the ancestral and alternate alleles as common natural variations across global populations, meaning neither form is considered a disruptive clinical mutation.
Biological Role of the MSRA Gene
The MSRA gene encodes methionine sulfoxide reductase A, an essential antioxidant repair enzyme found across mammalian tissues. Cellular metabolism constantly exposes proteins to reactive oxygen species, which can oxidize critical methionine residues into methionine sulfoxide. MsrA acts as a dedicated molecular repair system by specifically catalyzing the reduction of the S-stereoisomer of methionine sulfoxide back to functional methionine, thereby restoring normal enzymatic and structural protein activity. Animal models and biochemical investigations indicate that disruptions in MsrA signaling can lead to heightened cellular oxidative stress and alterations in systemic energy balance, insulin sensitivity, and visceral adiposity. Because chronic low-grade oxidative stress is closely interconnected with adipocyte hypertrophy and metabolic dysfunction, researchers frequently study the MSRA locus to understand how cellular antioxidant defenses might intersect with body composition and metabolic health.
GWAS Evidence: Strength and Limitations
Large meta-analyses of genome-wide association studies cataloged in resources like the GWAS Catalog have identified the MSRA chromosomal region as a statistical locus associated with obesity-related anthropometric traits, including body mass index, waist circumference, and body fat distribution. Nevertheless, the strength of evidence for rs4306591 acting as a primary causal driver is currently rated as limited. In common polygenic phenotypes, individual non-coding single nucleotide polymorphisms typically confer minute effect sizes, altering measures like body weight or waist circumference by only small fractions of a unit per risk allele. Furthermore, statistical associations observed in broad cohort studies frequently demonstrate ancestry-specific attenuation or fail to pinpoint the exact causal nucleotide due to extensive linkage disequilibrium. Therefore, while rs4306591 reflects genuine population-level variation in metabolic cohorts, it does not represent an isolated deterministic risk factor.
Population Frequency and Allelic Distribution
Data from large-scale reference databases, including the 1000 Genomes Project and the Genome Aggregation Database (gnomAD), confirm that rs4306591 is a common polymorphism globally. The minor allele is widely observed across diverse ancestral groups, including European, East Asian, South Asian, African, and Admixed American cohorts, although precise allele frequencies vary between geographic ancestries. Because the allele frequencies are relatively balanced in many global populations, all three possible genotypes—homozygous reference, heterozygous, and homozygous alternative—occur naturally and routinely in healthy individuals. The widespread prevalence of these alleles illustrates that carrying an association-linked allele is an ordinary human biological variation rather than a rare genetic disease or clinical abnormality.
Practical Interpretation and Context
When reviewing consumer or research genetic results, understanding the boundaries of genetic testing is essential. Your genotype at rs4306591 cannot diagnose obesity, metabolic syndrome, or any cardiovascular disorder, nor can it predict your future body weight. Common metabolic traits and body composition are shaped by hundreds of polygenic markers acting in concert with environmental factors, such as physical activity, sleep quality, stress, and dietary patterns. Lifestyle habits and broader medical history carry far more clinical significance than any single non-coding nucleotide change. Individuals curious about their personal metabolic health, weight management strategies, or family risk factors should discuss evidence-based interventions and objective clinical metrics—such as blood pressure, lipids, and glycemic markers—with a qualified physician or registered dietitian rather than relying on an isolated SNP result.
How common is this variant?
The rs4306591 variant is a common single nucleotide polymorphism observed at moderate to high frequencies across diverse reference populations in both the 1000 Genomes Project and gnomAD.
Frequently asked questions
Does having the rs4306591 risk genotype mean I will become overweight?
No. The statistical associations detected in genome-wide association studies represent very small, population-level effects rather than deterministic outcomes. Body weight and metabolic health are driven by a combination of hundreds of genetic variants alongside diet, physical activity, and environmental factors.
Can this genetic variant diagnose a metabolic disease?
No. The rs4306591 polymorphism is an intronic, non-coding variation and is not a clinical diagnostic marker. Medical diagnoses such as metabolic syndrome or obesity are determined through established clinical measurements, physical assessments, and laboratory tests.
What role does the MSRA gene play in the human body?
The MSRA gene encodes an antioxidant enzyme called methionine sulfoxide reductase A, which repairs proteins damaged by oxidative stress. While researchers study how oxidative stress pathways interact with adipose tissue and energy metabolism, normal daily variations in this gene rarely produce isolated symptoms.
Should I alter my diet or medications based on my rs4306591 result?
No. There are no clinical guidelines or pharmacogenomic recommendations advising dietary or medication modifications based on rs4306591 status. Any changes to your diet, exercise routine, or therapeutic medications should always be planned in consultation with a licensed healthcare professional.
Sources & further reading
Educational information only, last refreshed 9/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4306591?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29